Africa CDC and Bavarian Nordic Partner to Boost Mpox Vaccine Production in Africa

Signs and symptoms of mpox.
press release

Africa CDC has pledged to deliver 10 million Mpox vaccine doses by 2025, marking a significant commitment to strengthening health security across the continent. In support of this ambitious goal, Bavarian Nordic has joined forces with Africa CDC to enhance vaccine manufacturing capabilities within Africa. This partnership is set to play a crucial role in ensuring that up to 2 million doses are available this year, in addition to existing orders.

This collaboration is particularly vital in light of the recent declaration of the Mpox Public Health Emergency of Continental Security (PHECS), emphasizing the need for equitable vaccine access across African nations.

Learn more about this important partnership here: https://www.bavarian-nordic.com/investor/news/news.aspx?news=6970

Tagged:

AllAfrica publishes around 500 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.